Neurovalens to raise £5M in an equity deal led by Clarendon Fund Managers
09 August 2025
09 August 2025
Total investments received (USD): 17.3m
Round value (USD): 6.75m
Company: Neurovalens
Related deals
Bioliberty to raise a $8.2m Series A investment with Archangels, Eos Advisory, Old College Capital, Hanna Capital SEZC, and Conduit Connect.
Investments
21 January 2026
Emm raised a $9 million seed round led by Lunar Ventures and joined by Alumni Ventures, The Labcorp Venture Fund and BlueLion Global
Investments
03 November 2025
Delta.g raised £4.6M in Seed funding led by Serendipity Capital with participation from NSSIF, and existing investor SCVC.
Investments
11 September 2025
Everbloom raised $7.5 million pre-seed with Hoxton Ventures, SOSV, Endgame Ventures et al
Investments
04 August 2025
Ceryx Medical raised £5M with Development Bank of Wales, Parkwalk Advisors
Investments
03 June 2025
Netherlands
Austria
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
Spain